Compare SNX & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNX | ZBH |
|---|---|---|
| Founded | 1980 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7B | 16.0B |
| IPO Year | 2003 | 2001 |
| Metric | SNX | ZBH |
|---|---|---|
| Price | $268.39 | $86.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 21 |
| Target Price | ★ $198.70 | $101.00 |
| AVG Volume (30 Days) | 674.1K | ★ 2.0M |
| Earning Date | 03-31-2026 | 04-28-2026 |
| Dividend Yield | 0.86% | ★ 1.20% |
| EPS Growth | ★ 25.16 | N/A |
| EPS | ★ 4.04 | 1.22 |
| Revenue | ★ $20,053,764,000.00 | $8,231,500,000.00 |
| Revenue This Year | $9.11 | $4.96 |
| Revenue Next Year | $5.69 | $3.76 |
| P/E Ratio | ★ $68.75 | $71.07 |
| Revenue Growth | ★ 17.65 | 7.20 |
| 52 Week Low | $122.97 | $79.12 |
| 52 Week High | $286.25 | $108.29 |
| Indicator | SNX | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 70.04 | 56.45 |
| Support Level | $147.99 | $85.38 |
| Resistance Level | N/A | $87.22 |
| Average True Range (ATR) | 8.92 | 2.18 |
| MACD | 2.50 | 0.60 |
| Stochastic Oscillator | 71.23 | 73.91 |
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.